Cargando…
Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
OBJECTIVES: No randomized controlled trials have yet reported an individual patient benefit of initiating combination antiretroviral therapy (cART) at CD4 counts > 350 cells/μL. It is hypothesized that earlier initiation of cART in asymptomatic and otherwise healthy individuals may lead to poorer...
Ejemplares similares
-
Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
por: Jose, Sophie, et al.
Publicado: (2014) -
Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy
por: May, Margaret T., et al.
Publicado: (2014) -
Development and application of a new measure of engagement in out‐patient HIV care
por: Howarth, AR, et al.
Publicado: (2016) -
Associations with sub-optimal clinic attendance and reasons for missed appointments among heterosexual women and men living with HIV in London
por: Howarth, A R, et al.
Publicado: (2022) -
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study
por: Dolling, David I., et al.
Publicado: (2013)